Table 2

Sleep, Pain and Fatigue in SARS vs. FMS Subjects

Sleep Parameter

SARS (n = 22)

Fibromyalgia (n = 21)

Significance


Mean (SD)

Mean (SD)


Sleep onset latency ( min.)

24.13 (21.63)

18.37 (35.39)

n.s.


Total sleep time (min)

370.83 (83.84)

338.54 (76.26)

n.s.


Sleep Efficiency %

77.44 (13.56)

79.34 (15.63)

n.s.


Stage 1%

9.11 (4.13)

9.76 (3.66)

n.s.


Stage 2%

60.22 (9.95)

54.61(5.41)

0.031


Stage 3%

7.83 (6.36)

7.35 (3.08)

n.s.


Stage 4%

6.27 (5.80)

9.53 (6.18)

n.s.


REM onset Latency ( min.)

136.79 (63.72)

87.26 (35.78)

0.004


REM %

16.57 (5.94)

18.77 (4.81)

n.s.


Apnea/Hypopneas Index (no. per hr.of sleep)

4.70 (5.53)

3.29 (2.37)

n.s.


Periodic leg movements ( no.per hr of sleep)

2.03 (5.64)

2.38 (3.81)

n.s.


Arousals per hr of sleep

14.01 (7.59)

11.31 (5.31)

n.s.


CAP rate per hr of sleep

71.64 ()(14.25)

70.39 (15.64)

n.s.


Alpha EEG sleep (1-5)

3.00 (0.63)

3.50(0.61)

0.014


Presleep Pain Presleep Fatigue (1-7)

6.24 (4.01) 4.57 (1.57)

10.95 (5.74) 4.30 (1.08)

0.005 n.s.


Presleep Sleepiness (1-7)

2.76 (1.14)

4.30 (1.08)

0.0001


Post Sleep Pain (0-24)

7.10 (3.81)

11.75 (6.45)

0.009


Post Sleep Fatigue (1-7)

4.30 (1.87)

4.60 (1.23)

n.s.


Post Sleep Sleepiness (1-7)

3.45 (1.57)

3.90 (1.12)

n.s.


Moldofsky and Patcai BMC Neurology 2011 11:37   doi:10.1186/1471-2377-11-37

Open Data